Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Study of the Eztetic Dental Implant System (RoseQuartz)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03917927
Recruitment Status : Recruiting
First Posted : April 17, 2019
Last Update Posted : May 10, 2019
Sponsor:
Information provided by (Responsible Party):
Zimmer Biomet

Brief Summary:
This will be a prospective, observational multicenter study. All implants will be placed in the anterior maxilla or mandible and immediately loaded with a provisional prosthesis out of occlusion. Final restorations insertion will take place no later than 6 months following implant placement surgery. All implants will be restored with a single crown or splinted to a pre-existing implant if in the pre-molar region (no 2 adjacent edentulous sites).

Condition or disease Intervention/treatment Phase
Edentulous Jaw Device: Eztetic dental implant Not Applicable

Detailed Description:
This will be a prospective, observational study in which patients in need of dental implants in the anterior regions of the maxilla or mandible will be treated with the Eztetic dental implant(s). Qualified patients will be those with one or more edentulous area in the anterior maxilla or mandible needing a single (restored as a single crown; if in the pre-molar region, it is recommended implant be splinted to another tooth or implant; no 2 adjacent edentulous sites). Qualified patients should have presence of posterior teeth or a stable posterior occlusion. All implants will be placed in a single-stage manner. A provisional abutment will be placed and a temporary crown will be placed (cemented or screw-retained) out of occlusion at implant placement surgery visit. Impressions for permanent prosthesis fabrication will take place at 6 weeks and prosthesis placement will take place at 2 months. Final prosthesis insertion will take place no later than 6 months following implant placement surgery. Resonance frequency assessment procedures will be done at implant placement surgery and at prosthesis insertion. Implant survival will be the primary study endpoint. Crestal bone regression will be the secondary study endpoint. Enrollment will continue until 20 patients have completed final prosthetic treatment at study center.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective Multicenter Study of the Integration Success of the Eztetic Dental Implant System in Immediate Loading Cases
Actual Study Start Date : January 8, 2019
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2022

Arm Intervention/treatment
Experimental: Eztetic dental implant
Eztetic 3.1mm diameter, lengths 8, 10, 11.5, 13, 16 mm
Device: Eztetic dental implant
narrow diameter dental implant




Primary Outcome Measures :
  1. Implant survival [ Time Frame: 2 years ]
    survival (no declaration of failure) of dental implant


Secondary Outcome Measures :
  1. Marginal bone changes [ Time Frame: 2 years ]
    Change in bone levels around dental implant



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients of either sex and at least 18 years of age
  2. Patients for whom a decision has already been made to use a dental implant for the restoration of existing partial edentulism in the anterior (central and lateral incisors), canine or pre-molar regions in the mandible or maxilla. Placing implant in canine region should be in a healed site (not for immediate extraction)
  3. Immediate extraction or a prior extracted site
  4. Intact buccal table as verified by Cone Beam Computed Tomography (CBCT) or radiography during surgery. If absent, patient should be excluded from enrollment in the study.
  5. Patients must be physically able to tolerate conventional surgical and restorative procedures.
  6. Patients with a facial lingual width of at least 5.1mm and inner tooth width of at least 6mm.
  7. Patients having a thick gingival biotype (based on the lack of transparency of the periodontal probe through the gingival margin while probing the buccal sulcus) will be preferred but lack of this characteristic will not disqualify a patient from inclusion in this study.
  8. Presence of opposing dentition with a functional occlusion that permits the restoration with a non-occluding provisional prosthesis.
  9. Patients who provide a signed informed consent; a patient having implant placement surgery will continue participation in the study regardless of whether or not they receive restorative treatment according to protocol (protocol deviation)
  10. Patients who agree to be evaluated for each study visit.
  11. Minimum primary stability, insertion torque > 35Ncm (this will be a criteria that is met at the time of surgery)

Exclusion Criteria:

  1. Patients with known systemic diseases such as uncontrolled diabetes, endocrine disease, heart disease, immuno-compromised, or mental disorders.
  2. Patients with current use of non-steroidal anti-inflammatory drugs, bisphosphonates or corticosteroid treatments.
  3. Patients with active infection or severe inflammation in the areas intended for implant placement.
  4. Prisoners
  5. Patients with a > 10 cigarette per day smoking habit.
  6. Patients with a history of therapeutic radiation to the head or jaw.
  7. Patients in need of bone grafting at the site of the intended implantation site(s).
  8. Patients who are known to be pregnant at the screening visit or planning to become pregnant within 6 months of study enrollment.
  9. Patients with evidence of severe parafunctional habits such as bruxing or clenching.
  10. Patients with HIV or Hepatitis infection
  11. Patients who have previously failed implants at the site intended for study implant placement
  12. Patients in need of other treatments or surgeries at a site adjacent to the intended implantation site
  13. Patients with a history of severe periodontal disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03917927


Contacts
Layout table for location contacts
Contact: Cristina V Matthews 5617766722 cristina.matthews@zimmerbiomet.com
Contact: Hai BO Wen 561-776-6996 haibo.wen@zimmerbiomet.com

Locations
Layout table for location information
United States, Ohio
Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Contact: Burak Yilmaz, DDS    614-547-7900    messner.11@osu.edu   
Sponsors and Collaborators
Zimmer Biomet
Investigators
Layout table for investigator information
Principal Investigator: Burak Yilmaz, DDS Ohio State University

Layout table for additonal information
Responsible Party: Zimmer Biomet
ClinicalTrials.gov Identifier: NCT03917927     History of Changes
Other Study ID Numbers: 1601
First Posted: April 17, 2019    Key Record Dates
Last Update Posted: May 10, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Jaw, Edentulous
Jaw Diseases
Musculoskeletal Diseases
Stomatognathic Diseases
Mouth, Edentulous
Mouth Diseases
Tooth Diseases